ROYAL EMERALD PHARMACEUTICALS PARTNERS WITH BIOHARVEST SCIENCES TO SUPPLY DISRUPTIVE CANNABIS SOLUTIONS TO COMPANIES CONDUCTING FDA-APPROVED MEDICAL RESEARCH 2022, Uncategorized / Sam Chaloub ROYAL EMERALD PHARMACEUTICALS PARTNERS WITH BIOHARVEST SCIENCES TO SUPPLY DISRUPTIVE CANNABIS SOLUTIONS TO COMPANIES CONDUCTING FDA-APPROVED MEDICAL RESEARCH Read More »
BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES AND EXPECTS THE OFFERING TO BE OVERSUBSCRIBED AND TO CLOSE AN ADDITIONAL TRANCHE OF UP TO $3 MILLION BY DECEMBER 15, 2022 2022 / Sam Chaloub BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES AND EXPECTS THE OFFERING TO BE OVERSUBSCRIBED AND TO CLOSE AN ADDITIONAL TRANCHE OF UP TO $3 MILLION BY DECEMBER 15, 2022 Read More »
